Norway· NO-ID_7E17D04E-F4A9-435C-9E06-43C976343AAF
Zaditen
A ketotifen product containing ketotifen hydrogen fumarate, registered in Norway by Laboratoires Théa S.A.S. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ketotifen is registered in 13 of 19 countries.
Countries holding a registration under ATC S01GX08 (ketotifen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Ketotifen · ATC S01GX08
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Ketotifen Hydrogen Fumarate
- Manufacturer
- Laboratoires Théa S.A.S
- Country
- Norway (NO)
- ATC code
- S01GX08
- ATC class
- Ketotifen
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
1 priced- no_merkevare_idID_7E17D04E-F4A9-435C-9E06-43C976343AAF
- no_varenummer07504560 x 0.4NOK 327.2
- no_varenummer55132820 x 0.4
- gtin3662042005091
- gtin3662042005787
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ketotifen in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlawayBausch & Lomb Incorporated
- CzechiaZADITEN SDULaboratoires Thea, Clermont-Ferrand
- FinlandBentifenNovartis Healthcare A/S
- NetherlandsAltriabak 0,25 mg/ml, oogdruppels, oplossingLaboratoires Théa
- PolandKetotifen StullnPharma Stulln GmbH
- SwedenBentifen 0,25 mg/ml Ögondroppar, lösningLaboratoires THEA
- FranceKETAZED 0,25 mg/mL, collyre en solutionHORUS PHARMA
- BelgiumAltriabak 0.25 mg/mlPI Pharma
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Ketotifen Stulln, Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln
- Belgium · Altriabak, Ketazed
- Bulgaria · Ketotifen Sopharma, Забак
- Cyprus · Meni-Drops, Tenerel
- Czechia · Ketof, Ketotifen Al
- Germany · Allergo-Vision Sine, Ketazed
- Denmark · Ketazed, Zaditen
- Spain · Bentifen, Ketisal
- Finland · Ketazed, Ketotifen Stulln 0,25 Mg/Ml Silmätipat, Liuos
- France · Ketazed, Monoketo
- United Kingdom (Northern Ireland) · Ketazed, Ketofall
- Greece · Cleroptic, K-Drops
- Ireland · Ketofall, Zaditen
- Iceland · Zaditen
- Italy · Brunistill, Chetotifene Mylan Generics
- Luxembourg · Altriabak, Ketazed
- Latvia · Ketotifen
- Netherlands · Altriabak, Ketazed
- Poland · Ketotifen Hasco, Ketotifen Stulln
- Portugal · Lidina, Lidinafree
- Romania · Ketazed, Ketof
- Sweden · Bentifen, Ketazed
- Slovenia · Zaditen, Zaditen Sdu
- Slovakia · Denerel, Zaditen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df449c7e-0d9c-44da-bd9a-6bfdc190f40c GET /v1/drugs/df449c7e-0d9c-44da-bd9a-6bfdc190f40c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning i endosebeholder",
"source": "fest",
"status": "A",
"atc_name": "Ketotifen",
"merkevare_id": "ID_7E17D04E-F4A9-435C-9E06-43C976343AAF",
"name_form_strength": "Zaditen øyedr, oppl 0,25 mg/ml",
"prescription_group": "CF"
}See everything about ketotifen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.